Valentin Ceña

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (147)

• Hydrolytically Stable Cationic Bis-MPA Dendrimers as Efficient Transfectants for Glioblastoma Cells and Primary Astrocytes
  Biomacromolecules 2026 DOI: 10.1021/acs.biomac.5c01202
  +Save
• Fucoidan/bis-MPA-based dendrimer nanoparticles with intrinsic anti-angiogenic activity for oncology applications
  RSC Pharmaceutics 2026 DOI: 10.1039/D5PM00362H
  +Save
• The E193K LRRK2 mutation interferes with the autophagosome processing through the impairment of the LRRK2-Dynein-1 complex.
  Scientific reports 2025 DOI: 10.1038/s41598-025-26716-4
  +Save
• Preliminary Evidence for a Western Blot Diagnosis of Satoyoshi Syndrome Using SH-SY5Y Neuroblastoma Cell Lysate as the Antigen Source.
  Diagnostics (Basel, Switzerland) 2025 DOI: 10.3390/diagnostics15212797
  +Save
• Heterofunctional Cationic Polyester Dendrimers as Potent Nonviral Vectors for siRNA Delivery
  Pharmaceutics 2025 DOI: 10.3390/pharmaceutics17111476
  +Save
• siRNA Interaction and Transfection Properties of Polycationic Phosphorus Dendrimers.
  Biomacromolecules 2025 DOI: 10.1021/acs.biomac.5c00171
  +Save
• Lactate-coated polyurea-siRNA dendriplex: a gene therapy-directed and metabolism-based strategy to impair glioblastoma (GBM).
  Cancer gene therapy 2025 DOI: 10.1038/s41417-025-00906-8
  +Save
• Correction
  2025 DOI: https://doi.org/10.1038/s41417-025-00933-5
  +Save
• Special Issue Spanish Basic and Clinical Pharmacology.
  Pharmacological research 2024 DOI: 10.1016/j.phrs.2024.107265
  +Save
• In Vivo Applications of Dendrimers: A Step toward the Future of Nanoparticle-Mediated Therapeutics
  Pharmaceutics 2024 DOI: 10.3390/pharmaceutics16040439
  +Save